Bioprosthetic pulmonary valve dysfunction in a primary cardiac sarcoma survivor: Clinical considerations and treatment options-Reference-Cited by-同舟云学术

Bioprosthetic pulmonary valve dysfunction in a primary cardiac sarcoma survivor: Clinical considerations and treatment options

Published:2024-02 Issue:2 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Maione Davide¹²^ORCID,De Luca Antonio¹^ORCID,Pezzato Andrea¹²,Vitrella Giancarlo¹,Perkan Andrea¹,Rauber Elisabetta³,Butera Gianfranco⁴,Sinagra Gianfranco¹

Affiliation:

1. Cardiothoracovascular Department, Division of Cardiology Azienda Sanitaria Universitaria Giuliano‐Isontina and University of Trieste Trieste Italy

2. Postgraduate School of Cardiovascular Medicine University of Trieste Trieste Italy

3. Cardiothoracovascular Department, Division of Cardiac Surgery Azienda Sanitaria Universitaria Giuliano‐Isontina Trieste Italy

4. Division of Interventional Cardiology Children's Hospital Bambino Gesù Rome Italy

Abstract

Key Clinical MessageThe case highlights the good survival after radical surgery and chemotherapy of a cardiac sarcoma, and the need for close follow‐up due to possible early postsurgical complications.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8401

Reference8 articles.

1. Survival outcomes in patients with primary cardiac sarcoma in the United States

2. A case of primary cardiac sarcoma with an acute presentation: The role of multimodality imaging

3. A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature

4. Long-term durability of bioprosthetic valves in pulmonary position: Pericardial versus porcine valves

5. Valvular heart disease following anthracycline therapy—is it time to look beyond ejection fraction?;Zahler D;Life (Basel),2022